Top 10 Blue Chip Stocks To Watch For 2018

On Tuesday, stocks closed mixed with a preference for small-caps as they took gains in some blue chips and big-cap stocks.

Profit-taking started immediately, with a divergence of better-quality stocks being sold. Banks and other financials fell 1.4% at the close, while technology gained 0.9% and consumer discretionary rose 0.5%. Eight of the eleven sectors of the 500 lost ground. From the election until Monday most investing was based on the expectations that the new administration will increase fiscal spending and lower corporate tax rates. The goal is to raise interest rates, inflation and promote growth.

Yesterday buying slowed slightly, but floor traders said that consolidations are a good sign and that the “reflation trade” will probably resume again. The chief investment officer at Wells Fargo Private Bank was quoted by The Wall Street Journal who said “there’s a level of optimism I haven’t seen in a while.”

Crude oil WTI fell 0.7% at $45.56 per barrel due to an EIA report that crude oil supplies increased by 5.27 million barrels instead of an estimate of 1.48 million.

Top 10 Blue Chip Stocks To Watch For 2018: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Chris Lange]

    B&G Foods Inc. (NYSE: BGS) madewaves late on Friday after the company announced its most recent acquisition. B&G has now acquired Victoria Fine Foods from Huron Capital Partners and other sellers for roughly $70 million in cash.

Top 10 Blue Chip Stocks To Watch For 2018: Ethan Allen Interiors Inc.(ETH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump weighed on the healthcare sector, and some individual stocks took particularly hard hits. Among the worst performers were Perrigo (NYSE:PRGO), Novadaq Technologies (NASDAQ:NVDQ), and Ethan Allen Interiors (NYSE:ETH). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 10 Blue Chip Stocks To Watch For 2018: Immunomedics, Inc.(IMMU)

Advisors’ Opinion:

  • [By Chris Lange]

    Immunomedics, Inc. (NASDAQ: IMMU) saw its shares rise after the firm sent out a letter to shareholders imploring them to vote for its director nominees at the upcoming annual stockholders meeting on February 16. The board of directors is making this request because it is currently waging a proxy contest with venBio SelectAdvisor.

Top 10 Blue Chip Stocks To Watch For 2018: Transcananda Pipelines Ltd.(TRP)

Advisors’ Opinion:

  • [By Dustin Parrett]

    TransCanada Corp. (NYSE: TRP) just achieved a perfect Money Morning stock VQScore, making it a profit powder keg waiting to ignite…

    TransCanada is a Canadian oil and gas pipeline company, most famous for its development of the Keystone XL pipeline connecting Canadian oil fields to major hubs in the United States.

  • [By Paul Ausick]

    That includes pipeline companies like Kinder Morgan Inc. (NYSE: KMI), which already operates a pipeline transporting natural gas from Texas into Mexico, and master limited partnerships (MLPs) Energy Transfer Partners L.P. (NYSE: ETP) and TransCanada Corp. (NYSE: TRP), the company that has (so far) failed to get U.S. approval for its Keystone Pipeline expansion from Canada’s oil sands across the U.S. border.

  • [By Ben Levisohn]

    In a number of articles recently, following the US recent revival and potential approval of the previously blocked Keystone XL pipeline, a number of estimates have been provided suggesting a pending boom for the US steel industry is on the horizon (and US steel stocks have reacted in kind). In fact, this optimism, we believe, peaked today when a report from one of our competitors was published claiming that, the keystone XL pipeline could increase line pipe demand by 14.7% for 2 years. The problem here, we believe, rests with the facts that: (a) TransCanada (TRP) has already taken, and paid for, the steel to build the Keystone XL pipeline (the steel currently sits in storage facilities in both Regina, Canada and Arkansas, United States), (b) neither US Steel (X; SELL), AK Steel, Steel Dynamics, or Nucor have the ability to make the specialized steel required for the miles of pipe associated with this project, to include both the thickness and pressure requirements, according to this article from Reuters, and (c) assuming some of the pipe does need replacement, this would likely come from international steel makers who are capable of producing the specialized steel (again, as highlighted in this Reuters article).

  • [By WWW.KIPLINGER.COM]

    Energy stocks were driven by a hefty dose of M&A during the third quarter. And that will drive returns for TransCanada Corporation (TRP) during the next one.

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

  • [By Matthew DiLallo]

    After a series of setbacks in its attempts to build new oil pipelines, Canadian pipeline giant TransCanada (NYSE:TRP) completed a transformation transaction to acquire U.S. natural gas pipeline company Columbia Pipeline Group for $13 billion, which includes the assumption of debt. The key to that deal was that it increased the combined company’s near-term project pipeline to 23 billion Canadian dollars, which supports TransCanada’s ability to increase its dividend by 8% to 10% annually through 2020. After completing that deal, TransCanada made a bid to acquire all of the outstanding units that it did not own of affiliated MLP Columbia Pipeline Partners (NYSE:CPPL) in a transaction valued at $915 million. These acquisitions solidified TransCanada’s natural gas pipeline growth ambitions, enabling it to diversify away from oil pipelines.

Top 10 Blue Chip Stocks To Watch For 2018: Exa Corporation(EXA)

Advisors’ Opinion:

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
  • [By Monica Gerson]

    Exa Corp (NASDAQ: EXA) is projected to post a quarterly loss at $0.08 per share on revenue of $16.68 million.

    Thermon Group Holdings Inc (NYSE: THR) is estimated to report its quarterly earnings at $0.19 per share on revenue of $65.24 million.

Top 10 Blue Chip Stocks To Watch For 2018: Bioanalytical Systems, Inc.(BASI)

Advisors’ Opinion:

  • [By Lisa Levin] Related SOFO 12 Biggest Mid-Day Losers For Tuesday Earnings Scheduled For December 10, 2015
    Related WSCI 15 Biggest Mid-Day Losers For Wednesday Earnings Scheduled For June 21, 2016 Companies Reporting Before The Bell
    Rite Aid Corporation (NYSE: RAD) is projected to report its quarterly earnings at $0.04 per share on revenue of $8.23 billion.
    Conagra Brands Inc (NYSE: CAG) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.11 billion.
    Bioanalytical Systems, Inc. (NASDAQ: BASI) is expected to report earnings for the fourth quarter.

     

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Blue Chip Stocks To Watch For 2018: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.88 percent. Meanwhile, top losers in the sector included Simulations Plus, Inc. (NASDAQ: SLP), down 7 percent, and ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), down 7 percent.

Top 10 Blue Chip Stocks To Watch For 2018: Williams Partners L.P.(WPZ)

Advisors’ Opinion:

  • [By Ben Levisohn]

    In a release after the close on Monday, Williams and Williams Partners (WPZ) made several announcements, including: 1) outlining managements plan to financially reposition and simplify the franchises GP/LP structure in an ~$11.4 billion transaction (not subject to any additional approvals), 2) adjustments to Williams and Williams Partners’ dividend and distribution payouts, 3) initiating a ~$2+ billion William equity raise to fund a further Williams investment in Williams Partners, 4) noted other potential upcoming changes, including the sale of ~$2 billion in non-core assets in 2017, and 5) provided several forms of updated 2017 guidance…

Top 10 Blue Chip Stocks To Watch For 2018: James River Group Holdings, Ltd.(JRVR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of PhiloSmith Capital Corp’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=PhiloSmith+Capital+Corp

    These are the top 5 holdings of PhiloSmith Capital CorpPrimerica Inc (PRI) – 122,700 shares, 7.85% of the total portfolio. Chubb Ltd (CB) – 61,750 shares, 7.59% of the total portfolio. Reinsurance Group of America Inc (RGA) – 65,550 shares, 7.11% of the total portfolio. Brown & Brown Inc (BRO) – 193,225 shares, 7.03% of the total portfolio. Arthur J. Gallagher & Co (AJG) – 143,725 shares, 6.95% of the to

Top 10 Blue Chip Stocks To Watch For 2018: Boot Barn Holdings, Inc.(BOOT)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap apparel retailerBoot Barn Holdings (NYSE: BOOT) is the 4th most shorted stock on theNYSE with short interest of 54.59% according to Highshortinterest.com. Boot Barn Holdings is the nations leading lifestyle retailer of western and work-related footwear, apparel and accessories for men, women and children. The Company operates 219 stores in 31 states, in addition to an e-commerce channel www.bootbarn.com. The Company also operates www.sheplers.com, the nations leading pure play online western and work retailer. Sheplers has been part of the western, outdoor, and work lifestyle for over 100 years. Beginning in February 2017, the Company has operated www.countryoutfitter.com, an e-commerce site selling to customers who live a country lifestyle.

  • [By Peter Graham]

    Small cap western and work-related footwear/apparel retailerBoot Barn Holdings (NYSE: BOOT) reported fiscal Q3 2018 earnings asthe Company was the4th most shorted stock on theNYSE last September and still has elevatedshort interest of 37.26% according to Highshortinterest.com. Net sales increased 12.7% to $224.7 million due to an increase of 5.2% in same store sales, the sales contribution from seven new stores opened over the past twelve months and the four stores acquired from Woods Boots, and sales from the Country Outfitter site that was acquired in February 2017. Net income was $20.1 million versus $10.5 million, cash stood at$19.1 million at the end of the year and total net debt was $182.9 million. Forfiscal Q4 ending March 31, 2018, the Company expects:

  • [By Lisa Levin]

    Boot Barn Holdings Inc (NYSE: BOOT) shares dropped 15 percent to $6.30. Boot Barn reported weaker-than-expected results for its fourth quarter.

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

Leave a Reply

Your email address will not be published. Required fields are marked *